...Microarrays Hired: Steven Owings as VP of commercial development of prenatal diagnostics, formerly president of Primagen...

...angiogenesis biomarker. The license, which previously covered the cancer space, now includes the cardiovascular field. Primagen...

...Primagen granted bioMerieux exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen is...
...associated with respiratory disease in adults and the elderly. bioMerieux SA (Euronext:BIM), Marcy l'Etoile, France Primagen Holding B.V....

...Netherlands) granted bioMerieux (Euronext:BIM) exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen...

...Focus received a license to use Primagen's coronavirus NL63 DNA sequence and other IP to develop...
...for the virus, which is related to SARS . Focus Diagnostics Inc. , Herndon, Va. Primagen Holding B.V....

...Holdings B.V. , Amsterdam, the Netherlands Business: Diagnostic Hired: Steve Owings as president of Primagen's Primagen...

...Primagen develops molecular tests to detect DNA and RNA. Exponential Biotherapies , Amsterdam, the Netherlands Primagen Holding B.V....

...Delphic received exclusive rights to distribute and promote Primagen's Retina Mitox mitochondrial toxicity assay in the...
...mitochondrial toxicity assay in the U.K. and Ireland. Delphic Europe Diagnostics Ltd. , London, U.K. Primagen Holding B.V....

...The university granted Primagen an exclusive global license to commercialize its mitochondrial DNA detection and toxicity...
...detection and toxicity technology. The license relates to Primagen's Retina Mitox mitochondrial DNA/RNA measurement products. Primagen Holding B.V....

...Primagen received an exclusive worldwide license to Pharmasset's mitochondrial DNA detection and toxicity technology. Primagen said...
...and RNA markers predictive of adverse effects of antiviral therapy. Pharmasset Inc. , Atlanta, Ga. Primagen Holding B.V....